Risk Factors for Pediatric Emergence Agitation and Analysis of Serum or Urine Metabonomics in Children With Agitation
1 other identifier
observational
300
1 country
1
Brief Summary
It is known that some factors are associated with emergence agitation(EA), and investigators are still unable to predict accurately those who undergoing maxillofacial surgery are at great risks.This study intend to identify the risk factors for EA and to explore the mechanism of EA , which is helpful for early prediction, prevention and treatment in children.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Sep 2020
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 28, 2020
CompletedFirst Submitted
Initial submission to the registry
February 21, 2021
CompletedFirst Posted
Study publicly available on registry
March 19, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2021
CompletedNovember 19, 2021
November 1, 2021
1.2 years
February 21, 2021
November 12, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Risk factors for pain and emergence agitation following maxillofacial surgery in children
Children aged 3-12 years who undergoing palatopharyngoplasty/adenoidectomy or adenotonsillectomy, auricle reconstruction, and photodynamic therapy for vascular malformations were enrolled in this study. The general information of children, preoperative anxiety state, preoperative anxiety state of parents, operation type, anesthesia method, analgesic drug, postoperative pain and emergence agitation degree were collected. Multivariate regression analysis were conducted to identify the risk factors for pain and emergence agitation following maxillofacial surgery in children.
within 48 hours
The levels of serum and urine metabolites in EA
Children who underwent adenoidectomy or adenotonsillectomy in part I of this study were included. Urine (5ml) and peripheral venous blood (1ml) samples were collected before anesthesia and immediately after completion of agitation score. EA was defined as a Pediatric anesthesia emergence delirium(PAED) score ≥12 points. Children in EA group were matched with non-EA group, and UPLC-Q TOF/MS analysis was performed to identify the metabolites between two groups during the recovery period.
within 24 hours
Study Arms (2)
Group EA
Serum and Urine samples were collected before anesthesia and immediately after surgery from children who enrolled in part I and undergoing the adenoidectomy or adenotonsillectomy. A PAED score of 12 or greater was defined as EA. The serum and urine samples were analyzed by UHPLC-Q-TOF/MS separately.
Group non-EA
Serum and Urine samples were collected before anesthesia and immediately after surgery from children who enrolled in part I and undergoing the adenoidectomy or adenotonsillectomy. A PAED score less than 12 was defined as non-EA. The serum and urine samples were analyzed by UHPLC-Q-TOF/MS separately.
Eligibility Criteria
Patients undergoing palatopharyngoplasty/tonsillar and/or adenoidectomy, auricle reconstruction, and photodynamic therapy for vascular malformations on face.
You may qualify if:
- Patients undergoing palatopharyngoplasty/tonsillar and/or adenoidectomy, auricle reconstruction, and photodynamic therapy for vascular malformations on face.
- Aged between 3 years and 12 years.
- American Society of Anesthesiologists(ASA) class I-II.
You may not qualify if:
- Patients with developmental delays.
- Patients with mental disorders.
- Patients with severe liver and kidney damage,or other heart and lung disease.
- Reject to participate in the trials.
- Eligibility Criteria in Part II
- Patients who underwent adenoidectomy or adenotonsillectomy in part I of this study.
- Aged between 3 years and 7 years.
- American Society of Anesthesiologists(ASA) class I-II.
- Patients who underwent sevoflurane anesthesia maintainance.
- Patients with developmental delays or mental disorders.
- Patients with neurological or psychiatric diseases.
- Patients with severe liver and kidney damage,or other heart and lung disease.
- Patients with metabolic diseases or family inherited diseases.
- Patients who received drug treatment or intravenous nutritional supports.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Shanghai No.9 People's Hospital
Shanghai, China
Related Publications (1)
Li Y, Li J, Shi Y, Zhou X, Feng W, Han L, Ma D, Jiang H, Yuan Y. Urinary Aromatic Amino Acid Metabolites Associated With Postoperative Emergence Agitation in Paediatric Patients After General Anaesthesia: Urine Metabolomics Study. Front Pharmacol. 2022 Jul 19;13:932776. doi: 10.3389/fphar.2022.932776. eCollection 2022.
PMID: 35928271DERIVED
Biospecimen
Patients' blood and urine
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Jingjie Li, M.D
Shanghai No.9 People's Hospital
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- vice-director
Study Record Dates
First Submitted
February 21, 2021
First Posted
March 19, 2021
Study Start
September 28, 2020
Primary Completion
December 1, 2021
Study Completion
December 1, 2021
Last Updated
November 19, 2021
Record last verified: 2021-11
Data Sharing
- IPD Sharing
- Will not share